In the News May 28, 2019

The Deal | OncoSec Raises Capital to Fuel Clinical Trials

Alston & Bird is noted for representing OncoSec Medical Inc. in its $11 million initial public offering.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.